Pavel Šácha

1.7k total citations
63 papers, 1.2k citations indexed

About

Pavel Šácha is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pavel Šácha has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 22 papers in Oncology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pavel Šácha's work include Peptidase Inhibition and Analysis (18 papers), Neuropeptides and Animal Physiology (11 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Pavel Šácha is often cited by papers focused on Peptidase Inhibition and Analysis (18 papers), Neuropeptides and Animal Physiology (11 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Pavel Šácha collaborates with scholars based in Czechia, United States and France. Pavel Šácha's co-authors include Jan Konvalinka, Cyril Bařinka, Pavel Majer, Barbara S. Slusher, Petra Mlčochová, Jan Tykvart, Klára Hlouchová, Václav Navrátil, Vladimír Šubr and Josef Zámečnı́k and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Pavel Šácha

57 papers receiving 1.2k citations

Peers

Pavel Šácha
Niamh Moran Ireland
Kavindra Nath United States
Christian R. Lombardo United States
Paul T. Winnard United States
Weiping Jiang United States
Niamh Moran Ireland
Pavel Šácha
Citations per year, relative to Pavel Šácha Pavel Šácha (= 1×) peers Niamh Moran

Countries citing papers authored by Pavel Šácha

Since Specialization
Citations

This map shows the geographic impact of Pavel Šácha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Šácha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Šácha more than expected).

Fields of papers citing papers by Pavel Šácha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavel Šácha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Šácha. The network helps show where Pavel Šácha may publish in the future.

Co-authorship network of co-authors of Pavel Šácha

This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Šácha. A scholar is included among the top collaborators of Pavel Šácha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel Šácha. Pavel Šácha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dračínský, Martin, Jakob K. Reinhardt, Marjorie A. Liénard, et al.. (2025). Discovery and isolation of novel capsaicinoids and their TRPV1-related activity. European Journal of Pharmacology. 999. 177700–177700.
2.
Brungs, Corinna, Robin Schmid, Steffen Heuckeroth, et al.. (2025). MSnLib: efficient generation of open multi-stage fragmentation mass spectral libraries. Nature Methods. 22(10). 2028–2031.
3.
Zamani, Mohammad Reza & Pavel Šácha. (2025). Immune checkpoint inhibitors in cancer therapy: what lies beyond monoclonal antibodies?. Medical Oncology. 42(7). 273–273. 7 indexed citations
4.
Sedlák, František, et al.. (2024). Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and Brain Lipid Composition. ACS Chemical Neuroscience. 15(7). 1342–1355. 5 indexed citations
5.
Filipová, Marcela, et al.. (2024). Solid-Phase Synthesis as a Tool to Create Exactly Defined, Branched Polymer Vectors for Cell Membrane Targeting. Macromolecules. 57(3). 1050–1071. 5 indexed citations
6.
Zamani, Mohammad, et al.. (2024). Polymer-based antibody mimetics (iBodies) target human PD-L1 and function as a potent immune checkpoint blocker. Journal of Biological Chemistry. 300(6). 107325–107325. 2 indexed citations
7.
Zamani, Mohammad Reza & Pavel Šácha. (2024). TIM3 in COVID-19; A potential hallmark?. Heliyon. 10(23). e40386–e40386.
8.
Žáková, Lenka, Aleš Marek, Pavel Šácha, et al.. (2023). Insulin receptor Arg717 and IGF-1 receptor Arg704 play a key role in ligand binding and in receptor activation. Open Biology. 13(11). 230142–230142. 7 indexed citations
9.
Beranová, Jana, Libor Kostka, Vladimír Šubr, et al.. (2021). The development of a high-affinity conformation-sensitive antibody mimetic using a biocompatible copolymer carrier (iBody). Journal of Biological Chemistry. 297(5). 101342–101342. 4 indexed citations
10.
Sovová, Žofie, Pavel Májek, Jiřı́ Suttnar, et al.. (2020). Impact of posttranslational modifications on atomistic structure of fibrinogen. PLoS ONE. 15(1). e0227543–e0227543. 18 indexed citations
11.
Šácha, Pavel, Libor Kostka, Jiří Schimer, et al.. (2019). Inhibitor–Polymer Conjugates as a Versatile Tool for Detection and Visualization of Cancer-Associated Carbonic Anhydrase Isoforms. ACS Omega. 4(4). 6746–6756. 13 indexed citations
12.
Neburková, Jitka, František Sedlák, Libor Kostka, et al.. (2018). Inhibitor–GCPII Interaction: Selective and Robust System for Targeting Cancer Cells with Structurally Diverse Nanoparticles. Molecular Pharmaceutics. 15(8). 2932–2945. 22 indexed citations
13.
Navrátil, Václav, Jiří Schimer, Jan Tykvart, et al.. (2016). DNA-linked Inhibitor Antibody Assay (DIANA) for sensitive and selective enzyme detection and inhibitor screening. Nucleic Acids Research. 45(2). e10–e10. 13 indexed citations
14.
Schimer, Jiří, Maria Anders, Petr Pachl, et al.. (2015). Triggering HIV polyprotein processing by light using rapid photodegradation of a tight-binding protease inhibitor. Nature Communications. 6(1). 6461–6461. 25 indexed citations
16.
Mlčochová, Petra, Cyril Bařinka, Jan Tykvart, Pavel Šácha, & Jan Konvalinka. (2008). Prostate‐specific membrane antigen and its truncated form PSM′. The Prostate. 69(5). 471–479. 17 indexed citations
17.
Šácha, Pavel, et al.. (2007). Co nového víme o PSMA (prostatický specifický membránový antigen): z pohledu urologa. 1 indexed citations
18.
Šácha, Pavel, Josef Zámečnı́k, Cyril Bařinka, et al.. (2006). Expression of glutamate carboxypeptidase II in human brain. Neuroscience. 144(4). 1361–1372. 100 indexed citations
19.
Hlouchová, Klára, Cyril Bařinka, Vojtěch Klusák, et al.. (2006). Biochemical characterization of human glutamate carboxypeptidase III. Journal of Neurochemistry. 101(3). 682–696. 48 indexed citations
20.
Bařinka, Cyril, Petra Mlčochová, Pavel Šácha, et al.. (2004). Amino acids at the N‐ and C‐termini of human glutamate carboxypeptidase II are required for enzymatic activity and proper folding. European Journal of Biochemistry. 271(13). 2782–2790. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026